Page 2 - Frank Sciurba News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Many people have a lingering cough after a COVID infection. Experts explain why a post-COVID cough can last so long and what you can do to feel better.

Amoeba Biology Reveals Potential Treatment Target for Lung Disease Illustration of cilia and surface hydration among normal airway cells and those affected by cigarette smoke. Newswise — In a series of experiments that began with amoebas — single-celled organisms that extend podlike appendages to move around — Johns Hopkins Medicine scientists say they have identified a genetic pathway that could be activated to help sweep out mucus from the lungs of people with chronic obstructive pulmonary disease a widespread lung ailment. “Physician-scientists and fundamental biologists worked to...

Gala Therapeutics Receives FDA Approval to Commence Pivotal Trial to Evaluate the RheOx™ System for Chronic Bronchitis News provided by Share this article Share this article SAN CARLOS, Calif., Feb. 22, 2021 /PRNewswire/ -- Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, announces U.S. Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to commence its pivotal clinical trial called RheSolve, which is designed to evaluate the RheOx Bronchial Rheoplasty System for chronic bronchitis. Performed using a minim...